EN | RU
EN | RU

Help Support

Back

The efficacy of dextrose prolotherapy over placebo for temporomandibular joint hypermobility: a systematic review and meta-analysis

The efficacy of dextrose prolotherapy over placebo for temporomandibular joint hypermobility: a systematic review and meta-analysis The efficacy of dextrose prolotherapy over placebo for temporomandibular joint hypermobility: a systematic review and meta-analysis
The efficacy of dextrose prolotherapy over placebo for temporomandibular joint hypermobility: a systematic review and meta-analysis The efficacy of dextrose prolotherapy over placebo for temporomandibular joint hypermobility: a systematic review and meta-analysis

The systematic review aimed to investigate the possible evidence to evaluate the dextrose prolotherapy efficiency in recovering outcomes of temporomandibular joint (TMJ) hypermobility as compared to placebo.

See All

Key take away

The predicament of hypermobility within the temporomandibular joint is associated with pain, notable mouth opening and related degenerative disorders. The review attempts to evaluate the probability of an approach dextrose prolotherapy to alleviate temporomandibular joint hypermobility associated symptoms.

Background

The systematic review aimed to investigate the possible evidence to evaluate the dextrose prolotherapy efficiency in recovering outcomes of temporomandibular joint (TMJ) hypermobility as compared to placebo.

Method

The PubMed, Scopus, CENTRAL and Google scholar databases that published in the English language up to February 2018 were searched. Controlled clinical trials (CCTs) and Randomised clinical trials (RCTs) which made the comparison between dextrose prolotherapy and placebo to manage TMJ hypermobility were introduced.

Result

A total of three RCTs were incorporated in the evaluation. Two trials inscribed the subluxation/dislocation frequency which found with no difference within placebo and dextrose. On pooling of data, a statistically significant difference was noticed in the reduction of MMO with the dextrose prolotherapy use (random: MD = -3.32, 95% CI -5.26 to -1.28; P = 0.0008; I2 = 0%). the dextrose prolotherapy therapy also exhibited a statistically significant difference in pain reduction compared to placebo (random: MD = -1, 95% CI -1.58 to -0.42; P = 0.0007; I2 = 0%).

Conclusion

Inside the constraints of the study, dextrose prolotherapy may present with a meaningful reduction in mouth opening and pain allied with TMJ hypermobility. Findings concerning the reduction of episodes of subluxation/dislocation cannot be drawn. There is a requirement for further high-quality RCTs with larger sample size and homogenous prolotherapy protocol to bring substantial results on the influence of dextrose prolotherapy in patients with TMJ hypermobility. 

Source:

J Oral Rehabil

Article:

The efficacy of dextrose prolotherapy over placebo for temporomandibular joint hypermobility: a systematic review and meta-analysis

Authors:

Shakil Ahmed Nagori et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en
Try: